Literature DB >> 21276999

A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Gillian L Knight1, Alice G Pugh, Emma Yates, Ian Bell, Regina Wilson, Cary A Moody, Laimonis A Laimins, Sally Roberts.   

Abstract

The G2/M arrest function of human papillomavirus (HPV) E4 proteins is hypothesized to be necessary for viral genome amplification. Full-length HPV18 E1^E4 protein is essential for efficient viral genome amplification. Here we identify key determinants within a CDK-bipartite consensus recognition motif in HPV18 E1^E4 that are critical for association with active CDK-cyclin complexes and in vitro phosphorylation at the predicted CDK phosphorylation site (threonine 23). The optimal cyclin-binding sequence ((43)RRLL(46)) within this E4 motif is required for G2/M arrest of primary keratinocytes and correlates with cytoplasmic retention of cyclin B1, but not cyclin A. Disruption of this motif in the E4 ORF of HPV18 genomes, and the subsequent generation of stable cell lines in primary keratinocytes revealed that this motif was not essential for viral genome amplification or L1 capsid protein induction. We conclude that the HPV18 E4 G2/M arrest function does not play a role in early vegetative events.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276999      PMCID: PMC3722429          DOI: 10.1016/j.virol.2011.01.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  Modulation of the cell division cycle by human papillomavirus type 18 E4.

Authors:  Tomomi Nakahara; Akiko Nishimura; Masakazu Tanaka; Takaharu Ueno; Akinori Ishimoto; Hiroyuki Sakai
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium.

Authors:  J T Bryan; A Han; K H Fife; D R Brown
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

3.  Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.

Authors:  J A Wohlschlegel; B T Dwyer; D Y Takeda; A Dutta
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Changes in expression of the human homologue of the Drosophila discs large tumour suppressor protein in high-grade premalignant cervical neoplasias.

Authors:  Richard A Watson; Terry P Rollason; Gary M Reynolds; Paul G Murray; Lawrence Banks; Sally Roberts
Journal:  Carcinogenesis       Date:  2002-11       Impact factor: 4.944

5.  Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.

Authors:  F Toyoshima-Morimoto; E Taniguchi; N Shinya; A Iwamatsu; E Nishida
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

6.  The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts.

Authors:  Sally Roberts; Michele L Hillman; Gillian L Knight; Phillip H Gallimore
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Avian reovirus nonstructural protein p17-induced G(2)/M cell cycle arrest and host cellular protein translation shutoff involve activation of p53-dependent pathways.

Authors:  Julius L C Chulu; Wei R Huang; L Wang; Wen L Shih; Hung J Liu
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

8.  A bipartite substrate recognition motif for cyclin-dependent kinases.

Authors:  D Y Takeda; J A Wohlschlegel; A Dutta
Journal:  J Biol Chem       Date:  2000-11-06       Impact factor: 5.157

9.  Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16.

Authors:  Clare E Davy; Deborah J Jackson; Qian Wang; Kenneth Raj; Phillip J Masterson; Nicola F Fenner; Shirley Southern; Scott Cuthill; Jonathan B A Millar; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more
  21 in total

Review 1.  Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck.

Authors:  Grace C Blitzer; Molly A Smith; Stephen L Harris; Randall J Kimple
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-15       Impact factor: 7.038

2.  Genomic characterization of a novel Epsilonpapillomavirus associated with pigmented papillomas in a red deer (Cervus elaphus).

Authors:  John S Munday; Bernard L Vaatstra; Magdalena Dunowska; Rebecca E Laurie; Simon Hills
Journal:  Virus Genes       Date:  2016-05-06       Impact factor: 2.332

Review 3.  Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma.

Authors:  Daniel L Miller; Michael D Puricelli; M Sharon Stack
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

4.  Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.

Authors:  N Sanjib Banerjee; Hsu-Kun Wang; Thomas R Broker; Louise T Chow
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

5.  Human papillomavirus 18 E1^E4 protein interacts with cyclin A/CDK 2 through an RXL motif.

Authors:  Qingming Ding; Lili Li; Peter Whyte
Journal:  Mol Cell Biochem       Date:  2012-10-13       Impact factor: 3.396

Review 6.  Modulation of therapeutic sensitivity by human papillomavirus.

Authors:  Adam D Swick; Anirban Chatterjee; Anna-Maria A De Costa; Randall J Kimple
Journal:  Radiother Oncol       Date:  2015-09-10       Impact factor: 6.280

7.  Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.

Authors:  Emma L Prescott; Claire L Brimacombe; Margaret Hartley; Ian Bell; Sheila Graham; Sally Roberts
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

8.  E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.

Authors:  Ethan L Morgan; James A Scarth; Molly R Patterson; Christopher W Wasson; Georgia C Hemingway; Diego Barba-Moreno; Andrew Macdonald
Journal:  Cell Death Differ       Date:  2020-12-10       Impact factor: 15.828

9.  Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.

Authors:  Claudio Villota; América Campos; Soledad Vidaurre; Luciana Oliveira-Cruz; Enrique Boccardo; Verónica A Burzio; Manuel Varas; Jaime Villegas; Luisa L Villa; Pablo D T Valenzuela; Miguel Socías; Sally Roberts; Luis O Burzio
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

10.  Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.

Authors:  Kathryn H Richards; Rosella Doble; Christopher W Wasson; Mohammed Haider; G Eric Blair; Miriam Wittmann; Andrew Macdonald
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.